Genomic Health Announces Third Quarter 2009 Financial Results and Busines...(loss $(502) $...),Health

Date:11/4/2009

loss $(502) $(3,022) $(9,070) $(13,755) ========== ========== ========== ========== Basic and diluted net loss per share $(0.02) $(0.11) $(0.32) $(0.49) ========== ========== ========== ========== Shares used in computing basic and diluted net loss per share 28,579,045 28,331,505 28,538,915 28,270,776 ========== ========== ========== ==========

    GENOMIC HEALTH, INC.
    Condensed Consolidated Balance Sheets
    (In thousands)
                                                     As of           As of
                                                 September 30,   December 31,
                                                     2009            2008
                                                  (Unaudited)     (Unaudited)
                                                   ---------       ---------

    Cash and cash equivalents                        $16,719         $11,171
    Short-term investments                            42,183          45,499
    Accounts receivable, net                           9,655           8,807
    Prepaid expenses and other current assets          5,341           4,781
                                                   ---------       ---------
    Total current assets                              73,898          70,258

    Property and equipment, net                       13,235          15,562
    Restricted cash                                      500             500
    Other assets                                         477             369
                                                   ---------       ---------
    Total assets                                     $88,110         $86,689
                                                   =========       =========


    Accounts payable                    
'/>"/>
SOURCE  Genomic Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 
Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Microarray provides 3 genomic guides to breast cancer treatment decisions
3. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
4. Genomic Health to Present at ThinkEquity Partners Fifth Annual Growth Conference
5. Genomic profiling of lung tumors helps doctors choose most effective treatment
6. Genomic technologies to identify toxic chemicals should be developed
7. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
8. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
9. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
10. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
11. Genomic Health to Present at JMP Securities Healthcare Focus Conference